Acutus Medical Full Year 2023 Earnings US0.41 loss per share

AFIBDelisted Stock  USD 0.73  0.03  3.95%   
About 61% of Acutus Medical's investor base is looking to short. The analysis of overall sentiment of trading Acutus Medical stock suggests that many investors are alarmed at this time. The current market sentiment, together with Acutus Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Acutus Medical stock news signals to limit their universe of possible portfolio assets.
  
Acutus Medical Full Year 2023 Results Key Financial Results Revenue US7.16m down 56 percent from FY 2022...

Read at simplywall.st
Simply Wall St News at Macroaxis
  

Acutus Medical Fundamental Analysis

We analyze Acutus Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acutus Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acutus Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

Acutus Medical is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Acutus Medical Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Acutus Medical stock to make a market-neutral strategy. Peer analysis of Acutus Medical could also be used in its relative valuation, which is a method of valuing Acutus Medical by comparing valuation metrics with similar companies.

Peers

Acutus Medical Related Equities

AIMDAinos   4.44   
0%
82.0%
CVRXCVRx   3.20   
0%
59.0%
LNSRLENSAR   1.85   
0%
34.0%
AORTArtivion   0.95   
0%
17.0%
ANIKAnika Therapeutics   0.62   
0%
11.0%
OFIXOrthofix Medical   0.06   
0%
1.0%
SSKNSTRATA Skin   0.35   
6.0%
0%
DCTHDelcath Systems   2.01   
37.0%
0%
ATECAlphatec Holdings   2.46   
45.0%
0%
NPCENeuropace   2.62   
48.0%
0%
AXDXAccelerate Diagnostics   5.17   
95.0%
0%
AXGNAxogen   5.41   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Acutus Stock

If you are still planning to invest in Acutus Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acutus Medical's history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets